PYXS 424B2: Secondary offering

Pyxis Oncology, Inc.

Filed with the SEC on · accession 0001193125-26-372221

PYXS filed a 424B2 (prospectus (offering)) with the SEC on Aug 28, 2026. The final terms of an offering of shares or bonds. The stock moved -2.7% by the first close after the filing.

Summary of the filing

Pyxis Oncology, Inc. filed a prospectus supplement (424B2) for a secondary offering of common stock.

Key details

IssuerPyxis Oncology, Inc.

How PYXS stock reacted

Close before

$3.32

Aug 27, 2026

First close after

-2.71%

$3.23

5 trading days

+7.38%

$3.56

Since filing

-51.51%

$1.61

✦ Ask GOAX AI about this filing — what it means for PYXS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PYXS?

Click here

Frequently asked questions

What did PYXS file with the SEC on Aug 28, 2026?

PYXS filed a 424B2 (Secondary offering). Pyxis Oncology, Inc. filed a prospectus supplement (424B2) for a secondary offering of common stock.

What does a secondary offering mean for PYXS stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B2?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B2 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did PYXS stock react to this filing?

PYXS closed at $3.32 before the filing and $3.23 on Aug 28, 2026 (-2.71%). Five trading days later: $3.56 (+7.38%).

Other PYXS SEC filings

Get alerts when PYXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days